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Abstract  250 words max 
Oxidative stress is widely implicated in reproductive performance including infertility, 1 
miscarriage, diabetes-related congenital malformations and pre-eclampsia. Maternal 2 
obesity is a strong risk factor for pre-eclampsia, and recently, in an animal model of 3 
maternal obesity we have reported evidence of oxidative stress in the oocytes of 4 
obese animals prior to pregnancy as well as in early stage embryos. This adds to the 5 
growing evidence for a greater focus on the pre-conceptual period in prevention of 6 
pregnancy disorders including those related to oxidative stress. Our research has 7 
also focussed on the role of free radicals and antioxidant capacity in pre-eclampsia.  8 
Assessment by measurement of markers of lipid peroxidation or of antioxidant 9 
capacity has provided unequivocal evidence for oxidative stress in this disorder. 10 
Partial failure of the process of placentation has been implicated, with recent 11 
evidence proposing that ischaemia reperfusion in the placenta may contribute to 12 
oxidative stress in trophoblast. Endoplasmic reticulum stress in the placenta may 13 
also play a role. We and others have performed randomised controlled trials to 14 
determine whether early supplementation with vitamins C and E in women at risk of 15 
pre-eclampsia may be beneficial but these studies have shown no evidence for 16 
prevention of pre-eclampsia. Whether this represents an inappropriate antioxidant 17 
strategy or whether supplementation has been too late in gestation to be beneficial is 18 
not known. Other potential approaches to prevention of pre-eclampsia through 19 
amelioration of oxidative stress include provision of supplements in the pre-20 
conceptual period, selenium supplements, anti-peroxynitrite strategies and statins. 21 
22 
Oxidative stress, defined as an imbalance between pro-oxidants and antioxidant 23 
capacity, has been implicated in sub-optimal reproductive performance from the 24 
earliest stages of development through to labour and delivery. Reactive oxygen 25 
species (ROS) are substances with one or more unpaired electrons; because of this 26 
ROS are highly reactive, interacting with lipids, proteins or DNA leading to oxidation 27 
and cellular malfunction which may initiate pathological processes. The most 28 
commonly produced of the ROS in mammals is superoxide. Depletion of antioxidant 29 
capacity, whether through low abundance of non-enzymatic (e.g. vitamins C, E, 30 
glutathione) or enzymatic (e.g. superoxide dismutase, glutathione peroxidases, 31 
catalase) antioxidants renders the cell vulnerable to oxidative attack, even under 32 
physiological situations where redox status is maintained through careful balance of 33 
a low level of synthesis of reactive oxygen species and the pathways of cellular 34 
defence (Raijmakers MTM et al, Current Pharm Design 2004; Forman HJ et al 35 
Biochemistry 2010).   36 
 37 
Oxidative Stress and Fertility.    38 
Gametes are vulnerable to oxidative attack (Ruder EH et al, Human Reproduction 39 
Update 2009; Aitkin RJ and Iuliis Mol Human Reproduction 2010). Reduced fertility 40 
in men has been associated with oxidative damage to sperm. Human sperm is 41 
vulnerable to oxidant attack as it contains a very high content of polyunsaturated 42 
fatty acids, which are necessary to facilitate fusion with the oocyte, but are rich in 43 
double bonds which are prone to oxidation. The spermatozoa of subfertile patients 44 
contain high levels of 8-hydroxy-20-deoxyguanosine (8OHdG), the oxidation product 45 
formed when DNA is subjected to attack by ROS (Kodama H et al., Fertil and 46 
Sterility 1997). De Iuliis and colleagues have recently reported the presence of 47 
8OHdG adducts in human spermatozoa to be highly correlated with DNA strand 48 
breaks, determined using the TUNEL assay (De Iuliis et al., 2009). In a recent review 49 
Aitken and De Iuliis list the possible mechanisms which may result in DNA strand 50 
breaks in human sperm (Aitken and De Iuliis 2010). These include reduced 51 
antioxidant capacity in epididymal plasma or seminal fluid (as may occur in 52 
smokers), infection and iatrogenic ROS synthesis. These authors propose that the 53 
latter is predominantly derived from mitochondria and may be exacerbated in 54 
damaged sperm. It is suggested that damaged sperm, characterised by retention of 55 
residual cytoplasm, abnormal chromatin remodelling or abnormally high content of 56 
polyunsaturated fatty acids, will default to preferential activation of pathways of 57 
apoptosis. This in turn will lead to excess mitochondrial ROS synthesis. 58 
Mitochondrial oxidative phosphorylation necessarily leads to synthesis of free 59 
radicals through electron ‘leakage’ from the electron transfer pathway leading to 60 
generation of superoxide (O2●) and hydroxyl radicals (OH●) and mitochondrial 61 
activation in association with apoptosis can lead to excessive ROS synthesis and 62 
‘auto’ attack of the already vulnerable sperm, DNA oxidation and subsequent 63 
malfunction. Improved sperm function in vitro by addition of antioxidants has been 64 
repeatedly shown (Baker HW et al Fetility and Sterility 1996; Donnelly ET et al, 65 
Mutagenesis 2000) and it might be anticipated that antioxidant supplements would 66 
improve fertility in sub-fertile men. Several studies suggest that antioxidant 67 
supplementation may be of benefit in those subfertile men with proven oxidative 68 
damage in the sperm but there is no consensus of opinion in regard to the 69 
appropriate supplement or dose, and infertile men are not routinely tested for DNA 70 
fragmentation (Deepinder F et al, Endocr Pract 2008).  One study has reported the 71 
potential benefit of antioxidant supplementation (1 g vitamin C and 1 g vitamin E 72 
daily for 2 months) in men with already proven high levels of DNA oxidative damage 73 
and one failed ICSI attempt. The majority of the men demonstrated a reduction in 74 
DNA fragmented spermatozoa and improved ICSI success (Greco E, Human 75 
Reproduction 2005).  An improvement in fertility was also found in men with a high 76 
DNA fragmentation index instructed to consume a diet rich in antioxidants or 77 
commercial multivitamins containing beta-carotene, vitamin C, vitamin E, and zinc for 78 
at least 3 months (Gill Villa AM Fertility and Sterility 2009).  Our group have recently 79 
systematically reviewed the effect of oral antioxidants on male subfertility and 80 
concluded that supplementation could improve sperm quality and/or pregnancy 81 
rates; however large adequately powered trials using individual antioxidants are 82 
required (Ross et al., 2010).  83 
 84 
Oxidative stress also influences fertility in species other than man. An interesting 85 
corollary from the animal kingdom, recently published, is the recognition that 86 
amongst males of several avian species, those which are more brightly coloured are 87 
the more fertile. In the Great Tit (Parus major), the intensity of the yellow colour of 88 
the male breast has been related to the degree of carotenoid sufficiency, which in 89 
turn has been found to protect the sperm from lipid peroxidation, and thereby 90 
improve chances of reproductive success (Helfenstein F et al Eco Letters 2010).     91 
 92 
Oocyte quality is also affected by oxidative stress, and lower fertility rates in cigarette 93 
smokers, or in association with high levels of alcohol consumption, have been have 94 
been linked to increased ROS synthesis (Paszkowski T et al, Clin Chim Acta 236; 95 
1995; Jensen TK et al, BMJ 1998;317;  Eggert J et al, Fertil Steril 2004; 81;  Ruder 96 
EH et al 2008). As in many cellular processes, a low level of ROS synthesis fulfils an 97 
important role in cell signal transduction pathways, and in the oocyte, is a 98 
prerequisite for the first meiotic phase (MI) and also a requirement for 99 
folliculogenesis.  However excessive ROS synthesis will impair oocyte maturation 100 
(MII) and inadequate intracellular antioxidant capacity, particularly low 101 
concentrations of reduced glutathione (GSH), can limit successful ovulation and 102 
fertilisation (Ruder et al, 2008). Whilst there is good evidence that dietary antioxidant 103 
supplements can modulate fertility in rodents, there is as yet very limited evidence to 104 
suggest that periconceptional antioxidant supplementation should be recommended 105 
to improve fertility in women (Ruder et al, 2008; Cetin I et al, Human Reprod Update 106 
16; 2010). 107 
 108 
In vitro fertilization is also affected by excessive ROS in the embryo culture media, 109 
and the routine practice of incubation in a low oxygen tension prevents embryo 110 
arrest and enhances the chance of successful fertilization. (Ruder et al;, 2008)    111 
   112 
Obese women have a high rate of infertility, and assisted conception is often 113 
associated with a low success of oocyte fertilization, or of failure of embryo 114 
development (Pandey S and Battacharya S; Womens Health 2010). Several 115 
biomarkers of oxidative stress are increased in the blood of obese non-pregnant and 116 
pregnant individuals (Iyer A et al Nature Rev Endocrinol 2010; Jarvie E et al, Clin 117 
Science 2010). In a recent study we addressed the hypothesis that oxidative stress 118 
may be a contributory factor to reduced fertility in obese pregnancies (Igosheva N et 119 
al, PlosOne 2010). We explored the hypothesis that increased substrate availability 120 
for mitochondrial respiration may lead to oxidative stress in the oocyte and 121 
developing embryo. It is proposed that a high plane of nutrition may lead to 122 
excessive enrichment of the reproductive milieu (Robker RL et al, J Clin Endocrinol 123 
Metab 2009) and high rates of metabolism may compromise oocyte and embryo 124 
development, potentially through excessive mitochondrial ROS synthesis.  We 125 
determined whether obesity in the mouse is associated with increased mitochondrial 126 
activity in oocytes and early stage embryos.  C67BL/6J mice were fed a highly 127 
palatable diet or normal laboratory chow. After six weeks of the diet, females were 128 
induced to superovulate by hCG and oocytes were collected by puncture of pre-129 
ovulatory follicles. Zygotes and blastocysts were collected after successful mating 130 
with lean males after 24 and 84hr post hCG. Mitochondrial membrane potential, an 131 
indirect measure of mitochondrial activity, was determined with a mitochondrial 132 
specific membrane fluoroprobe (TMRM). Hyperpolarization of the membrane was 133 
observed in oocytes and zygotes retrieved from the obese females when compared 134 
to those from the lean animals. Redox status was assessed by measurement of the 135 
oxidative status of the pyridine  nucleotide (NAD(P)H) and the flavine nucleotide 136 
FAD++ , by measurement of autofluorescence. Both showed evidence of increased 137 
oxidation in oocytes and zygotes from the obese females. Direct measurement of 138 
free radical generation in in vitro ‘real time’ using the fluorescent dye dihydroethidium 139 
(HEt) also showed clearly that obesity was associated with increased ROS 140 
synthesis. Measurement of reduced glutathione using the fluorescent dye 141 
monochlorabimane (MCB) provided evidence of reduced cellular antioxidant 142 
capacity. ROS can also affect mitochondrial abundance and copy number and we 143 
found in the oocytes that mitochondrial DNA copy number was increased together 144 
with expression of nuclear genes encoding mitochondrial DNA transcription factors 145 
(mtTFAM and NRF1). The ability of zygotes to develop to the blastocyst stage was 146 
also reduced in the obese mice. To our knowledge this is the only study to have 147 
directly addressed redox status in oocytes and early embryos in obese animals and 148 
supports the hypothesis that oxidative stress may play a role in suboptimal fertility in 149 
obesity. 150 
Using the same model of murine obesity our laboratory also reported previously that 151 
the offspring later become hypertensive, demonstrate glucose intolerance and are 152 
fatter than controls (Samuelsson et al, Hypertension 2008). We also reported that 153 
the adult (3 month old) male offspring of the obese dams display a decrease in  the 154 
mitochondrial electron transport chain as shown by reduced mitochondrial-linked 155 
complex II-III (Shelley, McConnett et al, Am J Physiol 2009). Thus abnormal 156 
mitochondrial function is an accompaniment of obesity from the earliest stages of 157 
life. Whether this played a role in development of the phenotype described in the 158 
adult offspring of the obese dams, or whether it was a consequence remains to be 159 
determined but there is growing evidence that that the mitochondrion, which itself is 160 
particularly susceptible to DNA damage and has a modest capacity for repair, may 161 
be involved in the epigenetic processes associated with the developmental of 162 
adulthood disorders arising from nutritional imbalance in utero and in early post natal 163 
life (Simmons RA Rev End Met Dis 2007). Figure? 164 
 165 
Oxidative Stress and Early Pregnancy Loss. 166 
Oxidative stress has also been implicated in early miscarriage. Jauniaux and Burton 167 
have suggested that miscarriage may arise from premature oxygenation of the early 168 
embryonic environment. Using an O2 probe in women prior to first trimester 169 
termination they showed a steep rise in placental pO2 between 8 and 12 weeks of 170 
gestation, coincident with the establishment of maternal perfusion. Oxygenation was 171 
accompanied by upregulation of a battery of antioxidant defences including 172 
increased expression of catalase, glutathione peroxidise and Cu/Zn and Mn 173 
superoxide dismutase (Jauniaux E et al, Am J Pathol 2000).  The same group 174 
showed an increase in markers of oxidative stress in placental tissue from early 175 
pregnancy losses compared with controls and suggested that increased ROS 176 
generation may arise from a consequence of the premature establishment of 177 
maternal placental perfusion (Burton G, Jauniaux E, J Soc Gynecol Invest 2004). 178 
Whilst it might be anticipated that antioxidant supplements may provide some 179 
protection against miscarriage, metanalysis of all relevant studies suggests no 180 
substantive evidence for antioxidant supplements providing any benefit (Rumbold A, 181 
Middelton, Crowther, Cochrane Review 2005).  182 
 183 
Oxidative Stress and Pre-eclampsia. 184 
Pre-eclampsia, which affects approximately 2-7% of all pregnancies, is a syndrome 185 
associated with multi-organ dysfunction, characterised by new onset hypertension 186 
(blood pressure >140/90 mmHg) and proteinuria (>300 mg/L) after 20 weeks’ 187 
gestation (Brown et al., 2001). Other complications including stroke, convulsions, 188 
pulmonary edema, liver failure and thrombus formation make this a potentially life 189 
threatening condition for the mother and child (Villar J, Say L, Gulmezoglu AM et al. 190 
Eclampsia and pre-eclampsia: a worldwide health problem for 2000 years. In 191 
Critchley H, MacLean A, Poston L, Walker J ‘Pre-eclampsia’. London (UK) RCOG 192 
Press 2003; 189-207). Infant mortality and morbidity may also be may compromised 193 
by placental insufficiency leading to poor fetal growth. The precise mechanisms that 194 
lead to pre-eclampsia, which often occurs without warning and may follow a 195 
precipitous course are not known, but failure of the normal processes of 196 
placentation, followed by inadequate placental perfusion would seem to be a 197 
necessary prelude to the cascade of molecular events which culminate in the 198 
maternal syndrome (Redman CWG and Sargent IL, Placental Stress and Pre-199 
eclampsia, Placenta 2009). This is characterised by a marked exaggeration of the 200 
normal, mild inflammatory response which occurs in the pregnant woman, and is 201 
accompanied by vascular endothelial cell and platelet activation, and impairment of 202 
vascular endothelial dilator function (Redman CW, Sargent IL. Preeclampsia and the 203 
systemic inflammatory response. Semin Nephrol. 2004 Nov;24(6):565-70).  204 
 205 
The normal process of placentation involves remodelling of the maternal spiral 206 
arteries, the small resistance arteries of the uterine circulation responsible for blood 207 
supply to the placental intervillous space. The normally thick muscular wall of the 208 
spiral artery is rendered flaccid and non-contractile as the cytotrophoblast (placental 209 
epithelial cells) invade the decidua and myometrium of the uterine wall (Pijnenborg et 210 
al., 1980; Jauniaux et al., 2006). In pre-eclampsia this process is often incomplete 211 
and some vessels retain the smooth muscle layer (Whitley GS, Cartwright JE. 212 
Cellular and Molecular Regulation of Spiral Artery Remodelling: Lessons From the 213 
Cardiovascular Field. Placenta. 2010 Mar 30; doi:10.1016/j.placenta.2010.03.002 ). 214 
This in turn leads to reduced placental perfusion. The resultant hypoxia, together 215 
with intermittent reperfusion, is hypothesised to provoke ROS synthesis in the 216 
placenta (Burton, Hwang, Cindrova Davies, Placenta 2009; 23; S43). Numerous 217 
studies describe elevation of markers of oxidative stress in placental tissue from 218 
women with pre-eclampsia (Raijmakers, 2004 Current Pharmaceutical Desgin; 219 
Burton, Hwang etc 2009). Periods of ischaemia followed by reperfusion are 220 
associated with conversion of xanthine dehydrogenase to xanthine oxidase which is 221 
a potent source of superoxide (O2●) and xanthine oxidase activity is increased in the 222 
placentae of affected women (Many A, Hubel CA, Fisher SJ, Roberts JM, Zhou Y. 223 
Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am 224 
J Pathol. 2000 Jan;156(1):321-31). Recently, Burton et al have shown that hypoxia 225 
in placental tissue leads to endoplasmic reticulum (ER) stress, and activation of the 226 
unfolded protein response (UPR) (Burton GJ, H-W Yung Placenta 2009; 23; S43). 227 
ER stress leads to accumulation of misfolded proteins, which is the trigger for the 228 
unfolded protein response (UPR) that aims to restore ER homeostatic balance. 229 
Failure of this mechanism, which attempts to reconfigure the folding of proteins can 230 
lead to activation of apoptotic pathways and protein synthesis inhibition, which have 231 
been implicated by Burton and colleagues in the pathway to fetal growth restriction. 232 
Moreover ER stress is coupled to ROS synthesis, and ROS synthesis will increase 233 
with the degree of maternal spiral artery malfunction (Burton GJ, H-W Yung Placenta 234 
2009; 23; S43). Together ER stress and ROS synthesis are proposed to activate a 235 
cascade of pathways leading to cytokine release, prostaglandin synthesis, increased 236 
expression of anti-angiogenic factors (e.g. soluble Flt-1) and activation of apoptotic 237 
pathways. Other suggested contributors to ROS production include an activating 238 
autoantibody to the angiotensin 2 (ATII) receptor which is proposed to lead to ROS 239 
synthesis through activation of NADPH oxidase, a key cellular source of superoxide 240 
(Siddiqui AH, Irani RA, Blackwell SC, Ramin SM, Kellems RE, Xia Y. Angiotensin 241 
receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with 242 
disease severity. Hypertension. 2010 Feb;55(2):386-93). As summarised in figure 1, 243 
it is hypothesised that these disturbances of placental function may be causative of 244 
the maternal syndrome.     245 
 246 
Antioxidant Supplementation in Pre-eclampsia 247 
 The recognition of oxidative stress in the placenta, and also in the maternal 248 
circulation, prompted us to evaluate the potential benefit of prophylactic antioxidant 249 
supplementation in women with known risk of pre-eclampsia. At first we evaluated 250 
the effect of vitamin E and C supplements in women with known risk factors for pre-251 
eclampsia (abnormal uterine artery Doppler waveform or previous pre-eclampsia) 252 
(Chappell LC, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ, Parmar K, Bewley SJ, 253 
Shennan AH, Steer PJ, Poston L. Effect of antioxidants on the occurrence of pre-254 
eclampsia in women at increased risk: a randomised trial. Lancet. 1999 Sep 255 
4;354(9181):810-6). The study was designed to test the hypothesis that antioxidants 256 
would lead to reduction of biomarkers of maternal endothelial dysfunction, the ratio 257 
of Plasminogen Activator Inhibitor (PAI)-1: PAI-2 (PAI-1:PAI-2) being chosen as the 258 
primary outcome. In this small randomised controlled trial of 283 women, we showed 259 
that supplementation with 1gm vitamin C and 400IU of vitamin E daily from around 260 
16 weeks’ of gestation until delivery was associated with significant reduction in the 261 
PAI-1:PAI-2 ratio. We also reported a reduction in the plasma concentration of 8-epi 262 
prostaglandin F2α, a marker of lipid peroxidation, in association with elevation of the 263 
plasma vitamin C and E concentrations (Chappell LC, Seed PT, Kelly FJ, Briley A, 264 
Hunt BJ, Charnock-Jones DS, Mallet A, Poston L. Vitamin C and E supplementation 265 
in women at risk of preeclampsia is associated with changes in indices of oxidative 266 
stress and placental function. Am J Obstet Gynecol. 2002 Sep;187(3):777-84). 267 
Although not powered for pregnancy outcome the number of women who developed 268 
pre-eclampsia was lower in the antioxidant group compared with those women 269 
taking the placebo preparation. Encouraged by the evidence that antioxidants could 270 
improve oxidative stress and by the suggestion of reduced occurrence of the 271 
disease, we performed a randomised controlled trial in 2404 women, adequately 272 
powered to detect a difference in the incidence of pre-eclampsia, the primary 273 
outcome (Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH; Vitamins in Pre-274 
eclampsia (VIP) Trial Consortium. Vitamin C and vitamin E in pregnant women at 275 
risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet. 2006 276 
Apr 8;367(9517):1145-54). Although treatment compliance was good and despite 277 
evidence for improved antioxidant capacity in the blood, there was no difference in 278 
the number of women who developed pre-eclampsia between intervention (15%) 279 
and placebo (16%) arms. There was also a small but statistically significant increase 280 
in the incidence of low birthweight in the intervention arm (Risk Ratio 1.15 (1.02 to 281 
1.30). Three other large randomised controlled trials including one undertaken by the 282 
WHO in developing countries have also shown a lack of effect, conclusively proving 283 
that this antioxidant regime does not prevent pre-eclampsia either in high risk (Villar 284 
J, Purwar M, Merialdi M, Zavaleta N, Thi Nhu Ngoc N, Anthony J, De Greeff A, 285 
Poston L, Shennan A; WHO Vitamin C and Vitamin E trial group. World Health 286 
Organisation multicentre randomised trial of supplementation with vitamins C and E 287 
among pregnant women at high risk for pre-eclampsia in populations of low 288 
nutritional status from developing countries. BJOG. 2009 May;116(6):780-8) or lower 289 
risk  (Rumbold AR, Crowther CA, Haslam RR, Dekker GA, Robinson JS; ACTS 290 
Study Group. Vitamins C and E and the risks of preeclampsia and perinatal 291 
complications. N Engl J Med. 2006 Apr 27;354(17):1796-806; Roberts JM, Myatt L, 292 
Spong CY, Thom EA, Hauth JC, Leveno KJ, Pearson GD, Wapner RJ, Varner MW, 293 
Thorp JM Jr, Mercer BM, Peaceman AM, Ramin SM, Carpenter MW, Samuels P, 294 
Sciscione A, Harper M, Smith WJ, Saade G, Sorokin Y, Anderson GB; Eunice 295 
Kennedy Shriver National Institute of Child Health and Human Development 296 
Maternal-Fetal Medicine Units Network. Vitamins C and E to prevent complications 297 
of pregnancy-associated hypertension. N Engl J Med. 2010 Apr 8;362(14):1282-91) 298 
women. Two of these have also shown an increase in the incidence of gestational 299 
hypertension in the intervention arm (Poston; Roberts), although the observation of 300 
low birthweight found in our RCT has not been replicated in the subsequent trials. 301 
 302 
Why do antioxidants Vitamin C and E not prevent Pre-eclampsia?  303 
Despite overwhelming evidence for oxidative stress in pre-eclampsia, a regime of a 304 
vitamin C and E supplementation does not prevent pre-eclampsia. Amongst the 305 
several potential explanations, the first must be that oxidative stress, whilst 306 
undoubtedly present, plays no causative role in the aetiology of the disorder. This 307 
counters all the observational studies and extensive in vitro analyses detailing the 308 
responsible signalling pathways potentially involved. Until evidence to the contrary is 309 
presented, this explanation cannot be discounted. The second is that this antioxidant 310 
regime is inappropriate. Longitudinal blood sampling was performed in a sub-group 311 
of participants in the second trial of vitamins C and E from our group; 312 
supplementation leads to a significant fall in the plasma concentrations of γ-313 
tocopherol (Figure 2). The vitamin E preparation was given as natural source RRR α 314 
tocopherol, the stereoisomer that is preferentially absorbed in humans. The fall in γ-315 
tocopherol might be anticipated since dietary α and γ tocopherol compete in the liver 316 
for the tocopherol transfer protein (TTP) which facilitates uptake into the circulation 317 
(Hosomi A, Arita M, Sato Y, Kiyose C, Ueda T, Igarashi O, Arai H, Inoue K. Affinity 318 
for alpha-tocopherol transfer protein as a determinant of the biological activities of 319 
vitamin E analogs. FEBS Lett. 1997 Jun 2;409(1):105-8). However γ-tocopherol has 320 
biological activity, including anti-inflammatory properties; lowering of the blood 321 
concentration may impair the capacity to combat the inflammatory response of pre-322 
eclampsia (Devaraj S, Jialal I. Failure of vitamin E in clinical trials: is gamma-323 
tocopherol the answer? Nutr Rev. 2005 Aug;63(8):290-3; Reiter E, Jiang Q, Christen 324 
S. Anti-inflammatory properties of alpha- and gamma-tocopherol. Mol Aspects Med. 325 
2007 Oct-Dec;28(5-6):668-91). It was of interest that antioxidant supplementation 326 
also led to a significant fall in the plasma concentration of sflt-1, the anti-angiogenic 327 
soluble receptor for VEGF-1 which has been strongly implicated in development of 328 
pre-eclampsia, and a rise in placenta growth factor (PlGF) (Figure 3), but had no 329 
effect on endoglin. Studies in vitro have also shown that vitamins C and E prevent 330 
elevation of sFlt-1 in response to hypoxia- reperfusion in isolated placental 331 
trophoblast from normal pregnancies (Cindrova-Davies et al, Gabor Lecture Award 332 
Placenta 2009).  333 
 334 
It is also possible that the randomised controlled trials of antioxidants have provided 335 
the antioxidant supplements at too late a stage in gestation.  Although the recently 336 
reported study from the USA started antioxidants earlier in pregnancy than the other 337 
trials (9-16 weeks’ gestation) (Roberts et al 2010), there has been no study to 338 
address prophylaxis over the periconceptual period. It is of interest that in a large 339 
observational study in USA women, Bodnar et al have observed that regular use of 340 
multivitamin preparations in the peri-conceptual period was associated with a 45% 341 
reduction in pre-eclampsia risk compared with non-use (odds ratio 0.32-0.95) 342 
(Bodnar L et al. Am J Epidemiol 2006).  343 
 344 
Alternative Strategies? 345 
Vitamins C and E have little influence on the development of the peroxynitrite radical 346 
(ONOO●) formed from the interaction of nitric oxide (NO●, a nitrogen radical) with 347 
superoxide (O2●). In a recent study, Davidge’s group showed evidence for up-348 
regulation of the LOX- 1 receptor in the endothelium of small arteries dissected from 349 
omental biopsies obtained during Caesarean section from women with pre-350 
eclampsia (LOX-1 is the receptor for oxidised LDL), which on gaining access to the 351 
endothelium leads to an inflammatory response, stimulating macrophage 352 
transudation across the endothelial barrier; LOX-1 expression is stimulated by 353 
peroxynitrite and these authors showed in vitro that a peroxynitrite scavenger 354 
prevented upregulation of LOX-1 by pre-eclamptic serum in arteries from normal 355 
pregnant women (Sankaralingam S et al, Hypertension 2009). Thus anti-peroxynitrite 356 
strategies may be an alternative evidence-based strategy for reducing oxidative 357 
stress and improving endothelial function in affected women. Here, melatonin may 358 
be a potential candidate as it is a recognised scavenger of ONOO●, 359 
 360 
There is also a recognised association between essential micronutrient selenium 361 
status and pre-eclampsia, which may have implications for a different approach to 362 
prevention of oxidative stress. Several selenoproteins, notable the glutathione 363 
peroxidases, play an important role in cellular antioxidant defence by reducing lipid 364 
hydroperoxides to their corresponding un-reactive alcohols and reducing free 365 
hydrogen peroxide to water (Oster & Prellwitz, 1990; Rayman, 2000). 366 
Geographically, there are wide variations in dietary selenium intake depending on 367 
the selenium content of the soil. Pre-eclampsia has been linked to lower placental 368 
tissue, blood and toenail (long term status) selenium status and to reduced activity of 369 
glutathione peroxidases (Mistry et al 2008; Atamer et al, 2005; Rayman et al., 2003). 370 
Our group recently reported increased plasma concentrations of thiobarbituric acid 371 
reactive substances (TBARS; a marker for lipid peroxidation) in maternal and cord 372 
plasma in women with pre-eclampsia compared to controls; moreover, total 373 
glutathione peroxidase activity in both maternal and cord plasma and in placental 374 
tissue was significantly reduced and plasma activity positively related to the plasma 375 
selenium concentration (Mistry, et al. 2008). Selenium supplementation therefore 376 
offers another potential strategy for pre-eclampsia prevention particularly in 377 
geographical regions such as Europe with low soil selenium content (Thomson, 378 
2004). Further prospective, longitudinal studies are required to elucidate a ‘cause or 379 
effect’ relationship. A small randomised control trail of selenium supplementation 380 
(selenium in pregnancy; SPRINT) conducted in the UK is underway to asses the 381 
impact of selenium supplements on pre-eclampsia related biomarkers.  Perhaps 382 
unsurprisingly, dietary selenium insufficiency has been linked to infertility through 383 
oxidative stress. 384 
 385 
Theoretically, statins could play a role in prevention of pre-eclampsia, although 386 
safety in pregnancy must first be established. Statins offer a multi-pronged rationale 387 
as aside from improving the HDL:LDL cholesterol ratio statins have  anti-388 
inflammatory properties, as well as antioxidant effects through inhibition of NADPH 389 
oxidase (Montecucco F, Mach F. Update on statin-mediated anti-inflammatory 390 
activities in atherosclerosis. Semin Immunopathol. 2009 Jun;31(1):127-42).  391 
 392 
In summary, oxidative stress is associated with infertility, miscarriage and pre-393 
eclampsia, but there is at present little convincing evidence that antioxidant 394 
supplements can improve fertility, or prevent miscarriage or pre-eclampsia.  The 395 
breadth of strategies attempted has not been extensive, and there is a good 396 
evidence base to indicate well conducted, adequately powered trials which utilise 397 
other approaches. Safety and ethical considerations must however remain a 398 
predominant issue in any move towards other approaches.  399 
Figure XX: Plasma g-tocopherol concentration across gestation in 89 women on 400 
placebo and 95 women taking vitamin C and E supplementation; effect of 401 
supplementation: 0.49 (CI 0.43 – 0.57). 402 
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Figure XX: Plasma s-flt-1 concentration (logarithmic scale) across gestation in 45 405 
women on placebo and 54 women taking vitamin C and E supplementation; 406 
effect of supplementation: 0.48 (CI 0.19 to 0.67 over 16 weeks), p=0.037, 407 
compared to the placebo group. 408 
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Figure XX: Plasma PlGF concentration (logarithmic scale) across gestation in 45 411 
women on placebo and 54 women taking vitamin C and E supplementation; 412 
effect of supplementation: 2.1 (CI 1.03 to 4.40 over 16 weeks), p=0.037, 413 
compared to the placebo group. 414 
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